New Horizons in Nephrology: Glomerular Disease 2023: Update and Introduction to Upcoming Therapies

LIVECMEConferences & Symposia
New Horizons in Nephrology: Glomerular Disease 2023: Update and Introduction to Upcoming Therapies Banner

Add to Calendar New Horizons in Nephrology: Glomerular Disease 2023: Update and Introduction to Upcoming Therapies 9/8/2023 7:30:00 AM 9/8/2023 4:10:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/NewHorizons2023 Description: Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose... Virtual and Live false MM/DD/YYYY


Date & Location
Friday, September 8, 2023, 7:30 AM - 4:10 PM, Virtual and Live, Philadelphia , PA

Course Overview
Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which are associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases. The recently approved therapies and published guidelines are changing the clinical approach to diagnosis and management. Therefore, it is important for physicians to stay current with these new approaches to managing glomerular diseases.

Target Audience
Specialties - INTERNAL MEDICINE - Nephrology

Learning Objectives

After completing this activity, participants should be able to:


  1. Correctly diagnose and effectively treat membranous nephropathy using anti-PLA2R testing and advanced histology staining.
  2. Identify potential mechanisms responsible for disease progression in FSGS with emphasis on the role of genetic testing in clinical practice
  3. Discuss therapeutic options and the integration of recently approved therapeutics when treating lupus nephritis
  4. Identify potential mechanisms responsible for disease progression in IgA Nephropathy and the role of immunosuppression in the management
  5. Diagnose and treat monoclonal gammopathy of renal significance (MGRS)

Registration
LIVE AND VIRTUAL PRESENTATIONS
New Horizons in Nephrology: Glomerular Disease 2023: Update and Introduction to the Upcoming Therapies will be held Friday, September 8, 2023, at the University of Pennsylvania, in the Smilow Center for Translational Research, Rubenstein Auditorium, located in the Perelman Center for Advanced Medicine, 1st floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104.
 
REGISTRATION FEES (IN-PERSON ATTENDANCE)
The fee to attend in-person is $50 for all attendees. All pre-registered, in-person attendees will receive access to the conference, continental breakfast, lunch, and breaks. Registration also includes access to view the speaker presentations online for one year. Walk-ins are discouraged. Please register no later than September 6, 2023 so an accurate count may be made for food and beverages.
 
REGISTRATION FEES (LIVE-STREAM/VIRTUAL ATTENDANCE)
The fee to attend virtually is $25 and the deadline to register virtually is September 6, 2023. All registrants will receive conference materials via email 48 hours in advance of the meeting. All pre-registered virtual attendees will receive an email that includes a link with instructions to sign-in and join the virtual conference 48 hours preceding the conference.

All registrants will receive conference materials via email 48 hours in advance of the meeting.
 
DIRECTIONS
The Smilow Center for Translational Research, Rubenstein Auditorium, is located in the Perelman Center for Advanced Medicine, 1st floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104.
 
Parking & Public Transportation
The 3600 Civic Center Boulevard Parking Garage is available for parking and the non-patient parking rate is $20/day. It is a 5-minute walk to the Perelman Center and there is also a shuttle bus available at no charge. Parking fees will not be validated. Please note that the Perelman Center garage at 3400 Civic Center Boulevard is for patients only.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

DESIGNATION OF CREDIT
Physicians: Penn Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Credits
AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Attendance / Participation (7.25 hours)

Additional Information
CANCELLATION AND REFUND POLICY
In order to process refunds for course withdrawals, cancellations must be received via email by September 1, 2023, and are subject to a service charge equivalent to 10% of the registration fee. No refunds will be issued thereafter. Please email [email protected] regarding cancellations.
 
The University of Pennsylvania reserves the right to cancel or postpone this course due to unforeseen circumstances. In the event of a cancellation or postponement, the University will refund registration fees but is not responsible for fees assessed for travel or hotels.